Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,805 articles
Discover how your body's 24-hour internal clock controls everything from energy to aging — and what simple habits can keep it running smoothly.
Forever Healthy Foundation debuts a free, AI-audited encyclopedia covering 500+ longevity interventions with continuous evidence updates.
A 30-organization coalition targets Alzheimer's, Parkinson's, ALS and more by mapping which brain cells fail first — using human tissue and AI.
NewLimit's liver-targeting epigenetic reprogramming therapy heads to clinical trials after preclinical results arrived years ahead of schedule.
Spatial transcriptomics reveals how fibro-adipogenic progenitors signal macrophages via complement C3 to clear debris and drive elderly muscle repair.
A new mini review maps the most promising gene therapy targets for neurodegenerative, cardiovascular, metabolic, and eye diseases linked to aging.
Engineered telomerase RNA (eTERC) lengthens telomeres in patient iPSCs and blood stem cells, offering a potential therapy for telomere biology disorders.
Scientists built 3D human muscle organoids from stem cells, recreated age-related sarcopenia with TNF-α, and showed testosterone can partially reverse muscle loss.
A megakaryocyte-secreted protein declines with age and drives hematopoietic stem cell aging — and restoring it rejuvenates aged blood stem cells.
New research overturns the belief that the liver is spared from aging, revealing cell-level changes that fuel cancer, fatty liver, and frailty.
Dive into the molecular architecture of age-related membrane deterioration — from phospholipase regulation and lipid raft proteomics to ferroptosis thresholds, ceramide signaling networks, and emerging lipid-targeted interventions.
Longevity biotech NewLimit secures $435M in Series C funding, valuing it at $3.1B as it prepares its first clinical trial.
